~~<i id='4849698C7F'><strike id='4849698C7F'><tt id='4849698C7F'><pre id='4849698C7F'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：Wikipedia 2025-10-02 05:52:24 Page View：593

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Kansas must stop changing trans people's sex listing on driver's licenses, judge says
Next article： Medicare proposal to cover medical devices draws a mixed reaction

Wikipedia

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Adam's Biotech Scorecard: Do Sarepta's exon

ThisistheonlineeditionofAdam’sBiotechScorecard,asubscriber-onlynewsletter.STAT+subscriberscansignuph

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

What to know about a major upcoming Wegovy heart health study

AdobeAtsomepointthissummer,thedrugmakerNovoNordiskwillreleaseresultsfromacloselywatchedstudythat,ifs